Invesaro

Stocks Health care ADGM

NASDAQ · Health care

Adagio Medical Holdings, Inc. (ADGM)

Adagio Medical Holdings, Inc. brought in $0 of revenue over the twelve months to June 30, 2026. It posted a net loss of $27.1M. In fiscal 2025 capital spending exceeded operating cash flow by $19.4M. At June 30, 2026 it held $7.7M in cash against $24.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.

Price
$0.20
-7.14% on the day · September 25, 2026
52-week range $0.18 to $2.58
Market cap
$4.3M
Revenue (last 12 months)
$0

What Adagio Medical Holdings, Inc. does

Adagio Medical Holdings, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker ADGM.

Revenue and profit by year

Revenue
FY24: $300K $300K FY24FY25: $0 $0 FY25
Net income
FY24: -$36.6M -$36.6M FY24FY25: -$25.1M -$25.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$0-$21.9M-$25.1M-$1.51-$19.4M
2024$300K-$27.9M-$36.6M-$48.16-$26M

Full financial statements: income, balance sheet and cash flow

Next report expected around October 19, 2026.

Estimated from its filing rhythm: about 69 days after its last report of August 11, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What Adagio Medical Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 23, 2026
  2. August 14, 2026
  3. August 14, 2026
  4. August 13, 2026
  5. August 11, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.30 versus -$0.35.
  6. August 11, 2026
  7. July 28, 2026
  8. July 13, 2026
    Annual report (amended) 10-K/A · period to December 31, 2025Diluted EPS was -$1.51.
  9. June 16, 2026
  10. June 12, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 12, 2026. Insider transactions on SEC

Insider trades

What the people running Adagio Medical Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ADGM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Perceptive Advisors LLC13G, passive with 3 related filers 55.4% 15,321,655 May 15, 2026
Alyeska Investment Group, L.P.13G, passive with 2 related filers 9.9% 2,096,784 February 17, 2026
RA Capital Management, L.P.13G, passive with 3 related filers 7.2% 1,200,000 August 26, 2025
Adage Capital Management, L.P.13G, passive with 2 related filers 5.67% 1,258,501 May 13, 2026
ADAR1 Capital Management, LLC13G, passive with 1 related filers 5.4% 1,205,447 August 14, 2026

Latest filings below 5%: Sio Capital Management, LLC 3.15% (July 28, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ADGM

What does Adagio Medical Holdings, Inc. do?

Adagio Medical Holdings, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker ADGM.

Is Adagio Medical Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $27.1M.

How much revenue does Adagio Medical Holdings, Inc. make?

Over the twelve months to June 30, 2026 Adagio Medical Holdings, Inc. reported revenue of $0.

When did Adagio Medical Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the restructuring or layoffs from September 23, 2026.

Similar companies

Compare ADGM with

Compare ADGM with any company

Follow ADGM

Get an email when Adagio Medical Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow ADGM: get an email when it files

Where the numbers come from

Financial figures are the values Adagio Medical Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.